VitaSpring Biomedical Co. Ltd.

$0.01+0.00%(+$0.00)
TickerSpark Score
36/100
Weak
80
Valuation
35
Profitability
10
Growth
24
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VSBC research report →

52-Week Range0% of range
Low $0.01
Current $0.01
High $1.00

Companywww.vitaspringbio.com

VitaSpring Biomedical Co. Ltd. focuses on the development of drugs of cell medicine.

CEO
Ssu-Chuan Lai
IPO
2019
Employees
1
HQ
Irvine, CA, US

Price Chart

-98.89% · this period
$1.00$0.51$0.01May 19Nov 17May 19

Valuation

Market Cap
$2.30M
P/E
-0.55
P/S
0.00
P/B
-0.96
EV/EBITDA
-0.64
Div Yield
0.00%

Profitability

Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
1017.00%
ROIC
195.57%

Growth & Income

Revenue
$0 · -100.00%
Net Income
$-4,164,396 · -429.46%
EPS
$-0.02 · -431.15%
Op Income
$-4,177,836
FCF YoY
-756.51%

Performance & Tape

52W High
$1.00
52W Low
$0.01
50D MA
$0.01
200D MA
$0.66
Beta
-2.27
Avg Volume
76.508

Get TickerSpark's AI analysis on VSBC

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our VSBC Coverage

We haven't published any research on VSBC yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate VSBC Report →

Similar Companies